Screening Trial with the Coordinated Gold Compound Auranofin Using Mouse Lymphocytic Leukemia P388
作者： Dennis H. Kunishima , Timothy M. Simon , Arthur Lorber , Garry J. Vibert
DOI:
关键词:
摘要: … mice which re ceived the maximum Auranofin dosage of 6 mg/… positive control compound, ie, SFUra, to attain a T/C ratio of … However, animals given the chronic dosage of SFUra at 20 …
aacrjournals.org参考文章(6)
Timothy M. Simon, Dennis H. Kunishima, Garry J. Vibert, Arthur Lorber, Inhibitory effects of a new oral gold compound on HeLa cells. Cancer. ,vol. 44, pp. 1965- 1975 ,(1979) , 10.1002/1097-0142(197912)44:6<1965::AID-CNCR2820440602>3.0.CO;2-6
R I Geran, N H Greenberg, M M Mac Donald, PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS Cancer chemotherapy reports. ,vol. 3, pp. 1- 103 ,(1972)
Vibert Gj, Lorber A, Kunishima Dh, Simon Tm, Cellular antiproliferative action exerted by auranofin. The Journal of Rheumatology Supplement. ,vol. 5, pp. 91- ,(1979)
A E Finkelstein, A Misher, O R Burrone, D T Walz, Effect of auranofin on DNA and protein synthesis in human lymphocytes. The Journal of Rheumatology. ,vol. 4, pp. 245- 251 ,(1977)
Berglöf K, Berglöf Fe, Walz Dt, Auranofin: an oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. The Journal of Rheumatology. ,vol. 5, pp. 68- 74 ,(1978)
Wilcox Sa, Peter A, Leeb J, Lorber A, Simon Tm, Effect of chrysotherapy on parameters of immune response. The Journal of Rheumatology Supplement. ,vol. 5, pp. 82- 90 ,(1979)